Literature DB >> 2591064

Effects of Lugol's solution on thyroid function in normals and patients with untreated thyrotoxicosis.

T T Tan1, P Morat, M L Ng, B A Khalid.   

Abstract

Thirty-eight normal volunteers and 10 patients with untreated thyrotoxicosis were each given 0.5 ml of Lugol's solution daily for 10 days. On days 0, 5, 10, 15 and 20, serum levels of T4, free T4, T3 and TSH (by sensitive immunoradiometric assay) were measured. In normal subjects, the serum concentrations of free T4 declined significantly at day 10 while TSH levels were significantly increased at days 5, 10 and 15. Serum levels of T4 and T3 did not change significantly. All the observed changes took place within the limits of normal ranges for the hormones mentioned. In contrast, in the thyrotoxic subjects, both T4 and T3 were significantly decreased at days 5 and 10, while serum TSH remained below detection limit (0.14 mU/l) throughout the study. Short exposure to excessive iodide in normal subjects affects T4 and T3 release and this effect could be partially overcome by compensatory increase in TSH. In thyrotoxicosis, lack of compensatory increase in TSH results in rapid decreases in T4 and T3 levels. The integrity of the hypothalamo-pituitary-thyroidal axis may be effectively assessed by measuring TSH response to iodide suppression, using a highly sensitive immunoradiometric assay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591064     DOI: 10.1111/j.1365-2265.1989.tb00270.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves' disease: a single-center experience.

Authors:  Toyoyoshi Uchida; Hiromasa Goto; Takatoshi Kasai; Koji Komiya; Kageumi Takeno; Hiroko Abe; Nayumi Shigihara; Junko Sato; Akira Honda; Tomoya Mita; Akio Kanazawa; Yoshio Fujitani; Hirotaka Watada
Journal:  Endocrine       Date:  2014-02-04       Impact factor: 3.633

2.  Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease.

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Endocr Connect       Date:  2017-03-21       Impact factor: 3.335

Review 3.  Lugol's solution and other iodide preparations: perspectives and research directions in Graves' disease.

Authors:  Jan Calissendorff; Henrik Falhammar
Journal:  Endocrine       Date:  2017-10-26       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.